| Bionature enters Research Funding Agreement with Emergomed for Neuroprotect project. Release date March 2007 |
In March 2007 Bionature entered into a Research Funding Agreement with Emergomed for the Neuroprotect project (Click here to view project details) in order to pursue further research in the area of development of novel compounds for the treatment of neurodegenerative diseases.![]() The Chairman of the Emergo Group of Companies Mr. Alfred H. Balm with Dr. Achilleas Gravanis and Dr. Elias Castanas at the signing of the Neuroprotect Research Funding agreement. |